You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股收評:創業板指跌1.55%,油氣板塊全線回調,醫藥板塊重回風口

兩市指數震盪走低,滬指跌0.96%報3447.65點,深成指跌1.37%報13030.46點點,創業板指跌1.55%報2748.64點,日線4連陰。兩市個股跌多漲少,超3500只個股下跌。滬深兩市今日成交額10063億,較上個交易日縮量38億。

盤面上,恆泰艾普、仁智股份等一批強勢油氣概念大幅回落;新能源賽道股大跌靠前,鹽湖股份、寧德時代、比亞迪跌4%。教育股逆勢走強,半導體、煤炭板塊午後回落,山煤國際漲8%、兆易創新漲4%;醫藥股表現強勢,輔助生殖概念大漲,長江健康等多股漲停,仿製藥、新冠檢測、元宇宙、教育等概念活躍。

具體來看

油氣股全線回調,恆泰艾普跌超13%,海默科技、通源石油跌超12%,貝肯能源、仁智股份跌停,中曼石油跌超8%。

鋰電池概念股普跌,欣旺達跌超7%,天賜材料跌超5%,拓邦股份、鹽湖股份、恩捷股份、國軒高科跌超4%。

汽車板塊大跌,廣汽集團跌超5%,比亞迪、江淮汽車跌超4%,長安汽車、北汽藍谷、長城汽車紛紛下跌。

中國汽車工業協會根據13家重點企業上報的週報推算,2022年2月汽車行業銷量預計完成166.6萬輛,環比下降34.2%,同比增長13.8%;2022年1-2月累計預計完成419.6萬輛,同比增長5.7%。

醫藥商業板塊掀漲停潮,達嘉維康20cm漲停,瑞康醫藥、合富中國、開開實業、第一醫藥等多股10cm漲停,百洋醫藥漲超6%。

輔助生殖概念股暴漲,共同藥業20cm漲停,賽託生物漲近12%,長江健康、貝瑞基因、悦心健康漲停,漢商集團漲超3%。

消息面上,全國人大代表劉慶峯表示,落實鼓勵生育政策,除了優化生育福利之外,還要善用經濟“指揮棒”,為年輕人和用人單位減負,調動他們願意生育、支持生育的積極性。 

元宇宙午後衝高,恆信東方20CM漲停,中青寶漲超11%,美盛文化、元隆雅圖漲停,湯姆貓、絲路視覺漲超4%。

教育板塊表現活躍,昂立教育漲停,傳智教育、學大教育漲超3%,凱文教育、開元教育、中公教育等跟漲。

俄烏衝突加劇煤炭供應中斷擔憂,煤炭供需缺口或將進一步加大。煤炭股普漲,山煤國際漲近8%,昊華能源漲4.64%,晉控煤業漲近3%,陝西煤業、山西焦煤、平煤股份等跟漲。

今日,北上資金淨流入42.55億元,其中滬股通淨流入18.90億元,深股通淨流入23.65億元。

展望後市,海通證券指出,創業板指數仍有技術性超跌反彈走勢。在操作策略上,地緣風險構成短期擾動,對於A股市場的影響主要是心理層面,但對市場長期實際影響有限,近期以美國為首的西方國家加大了對俄羅斯的經濟制裁,短期可關注中俄貿易概念的港口、物流、航運等板塊。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account